LobbyingHelix lobbying by quarter
Helix's latest lobbying report covers Q4 2024, at $10K. Its first report covers Q2 2021; the issues it reports most are Health Issues and Medical/Disease Research/Clinical Labs.
Helix
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $0
- Last 4 quarters
- vs last quarter
- No record
- Q3 2026 against the quarter before
- First report
- Q2 2021
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q2 2021 | $70K | 1 |
| Q3 2021 | $110K | 1 |
| Q4 2021 | $110K | 1 |
| Q1 2022 | $110K | 1 |
| Q2 2022 | $110K | 1 |
| Q3 2022 | $130K | 1 |
| Q4 2022 | $100K | 1 |
| Q1 2023 | $120K | 1 |
| Q2 2023 | $130K | 1 |
| Q3 2023 | $90K | 1 |
| Q4 2023 | $75K | 1 |
| Q1 2024 | $83K | 1 |
| Q2 2024 | $80K | 1 |
| Q3 2024 | $80K | 1 |
| Q4 2024 | $10K | 1 |
| Q1 2025 | $0 | 0 |
| Q2 2025 | $0 | 0 |
| Q3 2025 | $0 | 0 |
| Q4 2025 | $0 | 0 |
| Q1 2026 | $0 | 0 |
| Q2 2026 | $0 | 0 |
| Q3 2026 | $0 | 0 |
By issue
- Health issues$481.8K · 15 reports
- Medical research and clinical labs$481.8K · 15 reports
- Budget and appropriations$279.3K · 10 reports
- Science and technology$85.8K · 5 reports
- Defense$63.3K · 3 reports
- Veterans$15.8K · 2 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- HOUSE OF REPRESENTATIVES15 reports
- SENATE15 reports
- Centers For Disease Control & Prevention (CDC)13 reports
- White House Office6 reports
- Food & Drug Administration (FDA)3 reports
- Health & Human Services, Dept of (HHS)3 reports
- Natl Institutes of Health (NIH)3 reports
- Veterans Affairs, Dept of (VA)3 reports
- Defense, Dept of (DOD)2 reports
- Office of Management & Budget (OMB)1 reports
Firms it paid
| Firm | ||
|---|---|---|
| In-houseHelix | $1.4M | 15 quarters |
Former officials lobbying for it
No lobbyist with a covered position.
Lobbying reports
| Filed by | ||
|---|---|---|
| 24/12/17for Q4 2024 | In-house | $10K |
| 24/09/30for Q3 2024 | In-house | $80K |
| 24/07/01for Q2 2024 | In-house | $80K |
| 24/04/01for Q1 2024 | In-house | $83K |
| 24/01/03for Q4 2023 | In-house | $75K |
| 23/10/02for Q3 2023 | In-house | $90K |
| 23/08/03for Q4 2021 | In-house | $110K |
| 23/08/03for Q3 2021 | In-house | $110K |
| 23/08/03for Q2 2021 | In-house | $70K |
| 23/08/03for Q4 2022 | In-house | $100K |
| 23/08/03for Q3 2022 | In-house | $130K |
| 23/08/03for Q2 2022 | In-house | $110K |
| 23/08/03for Q1 2022 | In-house | $110K |
| 23/08/03for Q1 2023 | In-house | $120K |
| 23/07/26for Q2 2023 | In-house | $130K |
| 23/07/05for Q2 2023 | In-house | $40K |
| 23/04/03for Q1 2023 | In-house | $40K |
| 23/01/05for Q4 2022 | In-house | $40K |